These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16784098)

  • 1. [Complication of topoisomerase II inhibitor-related acute promyelocytic leukemia with t(1;10) (q21;q26) in a patient with Sézary syndrome].
    Miyoshi N; Noda M
    Rinsho Ketsueki; 2006 May; 47(5):399-401. PubMed ID: 16784098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
    Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 2000 Sep; 41(9):750-4. PubMed ID: 11070938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy-related acute promyelocytic leukemia with a t(9;22)(q34;q11) and t(15;17)(q22;q11 to approximately 12) subclone].
    Mochiduki Y; Muramoto S
    Rinsho Ketsueki; 2005 Nov; 46(11):1218-22. PubMed ID: 16440807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Small cell lung cancer with Sézary syndrome].
    Nakanishi M; Kubota Y; Hara H; Ueda M; Arimoto T; Iwasaki Y
    Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1135-40. PubMed ID: 20058693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gemtuzumab ozogamicin successfully induced molecular remission in relapsed therapy-related acute promyelocytic leukemia].
    Shimokawa T; Kojima Y
    Rinsho Ketsueki; 2008 Apr; 49(4):270-2. PubMed ID: 18516871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sézary syndrome with ascitis: case report and review of the literature].
    Nubourgh I; Van den Broeck K; Bradstreet C; Praet JP; Cantinieaux B
    Rev Med Brux; 2005; 26(5):445-50. PubMed ID: 16318098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular Sézary syndrome with bullous lesions on the feet.
    Dehesa L; Bastida J; Camacho-Galán R; Campos-Adsuar C; Gómez-Duaso J; Vilar-Alejo J
    Eur J Dermatol; 2009; 19(3):282-3. PubMed ID: 19258239
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 11. [Renal insufficiency caused by leukemic cell infiltration in Sézary syndrome].
    Tanaka Y; Nagai K; Tani M; Watanabe N; Kurata M; Matsushita A; Maeda A; Yamashita E; Shirane H; Takahashi T
    Rinsho Ketsueki; 2005 May; 46(5):368-71. PubMed ID: 16444971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related acute promyelocytic leukemia following etoposide-based chemotherapy in non-seminomatous germ cell tumor.
    Kumar TN; ; Gandhi LV; Raghunadharao D; Sadashivudu G
    J Postgrad Med; 2014; 60(1):84-5. PubMed ID: 24625948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
    Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
    Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sézary syndrome associated with hepatocellular carcinoma and monoclonal gammopathy--a case report].
    Shimamura R; Kaneko T; Morioka E; Shibuya T; Ishibashi H; Niho Y
    Rinsho Ketsueki; 1989 Jul; 30(7):1067-73. PubMed ID: 2554013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
    Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
    Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia].
    Hisatake J; Shimozuma J
    Rinsho Ketsueki; 2008 Jun; 49(6):408-12. PubMed ID: 18646608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Sézary cryptogram. Disseminated cryptococcal infection.
    Desar IM; Stevens WB; Verweij PE; van der Velden WJ
    Neth J Med; 2011; 69(7):346, 349. PubMed ID: 21934182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.